Resultados de la búsqueda 11-20 of 158 for Raised INR

1. Puntuación del modelo para la enfermedad hepática terminal - Atención médica en Mayo Clinic

   Increased INR values predict accelerating deterioration and high short-term mortality among patients hospitalized with cirrhosis or advanced fibrosis.

2. Puntuación del modelo para la enfermedad hepática terminal - Médicos y departamentos - Mayo Clinic

   Increased INR values predict accelerating deterioration and high short-term mortality among patients hospitalized with cirrhosis or advanced fibrosis.

3. Hematología - Ensayos clínicos - Mayo Clinic

   This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

4. Puntuación del modelo para la enfermedad hepática terminal - Médicos y departamentos - Mayo Clinic

   Increased INR values predict accelerating deterioration and high short-term mortality among patients hospitalized with cirrhosis or advanced fibrosis.

5. Enfermedad de las arterias coronarias.

   Publicaciones · Ferri FF. Coronary artery disease. · Coronary heart disease. National Heart, Lung, and Blood Institute. · Usatine RP, et al., eds. · Wilson PWF.

6. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. The overall objective of this study is to define genes causing cystic kidney disease and to determine the degree to which variants at these ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...

8. Mayo Clinic Cardiovascular Physician Update - September 2025

   Page 1.

9. Hipertrofia ventricular izquierda

   High blood pressure. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health-topics/high-blood-pressure. Accessed June 22, 2022. Medical ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...